Sunesis Pharmaceuticals ( SNSS) is a biopharmaceutical company engaged in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. This stock closed up 1.4% to $5.61 in Tuesday's trading session.
Tuesday's Range: $5.38-$5.62
52-Week Range: $2.30-$6.85
Tuesday's Volume: 614,000
Three-Month Average Volume: 345,849
Twitter and become a fan on Facebook.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts